Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

India’s Nexavar patent ruling disturbs pharma

March 12, 2012 Sales and Marketing India, emerging markets, intellectual property, patents

India is to allow Bayer’s cancer treatment Nexavar to be subject to a compulsory licence, allowing a generic firm to …
News

Government could be forced to publish risk register

March 9, 2012 Sales and Marketing Healey, NHS, reforms, risk

The government has lost its appeal to keep details about the risks involved in the reform of the NHS secret.  …
News
caprelsa image

Major new drugs for 2012

March 9, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Caprelsa, Eylea, Manjor new drugs, Xalkori, Zelboraf, avastin, inlyta

 Renal cell carcinoma Pfizer’s Inlyta (axitinib) has been approved as second line treatment for renal cell carcinoma. The drug is …
Feature
mark_archer_013

inVentiv appoints former Quintiles man Mark Archer

March 9, 2012 Business Services, Medical Communications, Sales and Marketing Merck, Quintiles, Roche, Sanofi, inVentiv

Pharma consultants inVentiv Health has appointed Mark as its new senior vice president of European operations and development for inVentiv …
Appointment

Government touts telehealth scheme

March 9, 2012 Medical Communications, Sales and Marketing NHS, king's fund, telecare, telehealth

The government has said that telehealth and telecare technology could save the NHS £1.2 billion over the next five years.  …
News
Victrelis picture

NICE recommends Victrelis in speedy review

March 9, 2012 Sales and Marketing Incivo, Janssen, Merck, NICE, Pegasus, Victrelis

NICE is recommending Merck’s hepatitis C pill Victrelis for funding in the NHS, in an expedited review.  In its final …
News
rachel_terry

Aurora bolsters senior team with new director

March 8, 2012 Business Services, Medical Communications, Sales and Marketing Aurora, LoweFusion, Pan

Aurora has appointed Rachel Terry as its new director.Terry was previously director of healthcare at Burson-Marsteller until the end of …
Appointment

Keep Alzheimer’s patients on Aricept for longer, study says

March 8, 2012 Research and Development, Sales and Marketing Aricept, Pfizer, Teva, donepezil

Patients with severe forms of Alzheimer’s disease should stay on Pfizer’s Aricept for longer, according to new research. A new …
News
Novartis image

Novartis Indian patent battle nears conclusion

March 7, 2012 Sales and Marketing Glivec, HIV, India, Novartis, patents

A long-running battle over the patent of cancer treatment Glivec in India is about to reach its dramatic climax.India’s Supreme …
News

Sandoz falls foul of ABPI Code

March 7, 2012 Medical Communications, Sales and Marketing ABPI Code of Practice, Sandoz

Sandoz has been rapped over the knuckles for offering non-approved bags and bottles to patients.It was found to be offering …
News

Onyx appoints Luigi Costa as its new vice president of Europe

March 7, 2012 Sales and Marketing Luigi Costa, Onyx

Onyx Pharmaceuticals International has appointed Luigi Costa as vice president and head of its European division.  Costa will report to …
Appointment
Zytiga image

Cancer Drugs Fund should not be used across the UK

March 7, 2012 Sales and Marketing CDF, Janssen, NICE, Zytiga, myloma, prostate

The Prostate Cancer Charity has said that extending England’s Cancer Drugs Fund to the UK will not solve the issue …
News
mark_baker_photograph2

NICE appoints two new directors

March 7, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mark Baker, NICE

The National Institute for Health and Clinical Excellence (NICE) has appointed two new directors. Professor Mark Baker will be the …
Appointment
Antonio Tajani

Can Europe really agree to speed up pricing and reimbursement?

March 6, 2012 Sales and Marketing Europe, European Commission, GSK, Sir Andrew Witty, pricing and reimbursement

The European Commission has called for faster decisions to allow new medicines to enter the market faster.The Commission says the …
Feature

Ranbaxy launches generic Lipitor in Europe

March 6, 2012 Research and Development, Sales and Marketing Lipitor, Pfizer, Ranbaxy, atorvastatin, generics

Ranbaxy has launched its generic version of Pfizer’s Lipitor in Europe, months ahead of its May expiration date.  The Indian …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 3, 2026

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026